Communiqué de presse
Sofinnova Partners annonce la vente de Corvidia Therapeutics à Novo Nordisk
Novo Nordisk acquiert Corvidia pour 2,1 Mds$ avec un paiement initial de 725 M$ en cash Sofinnova Partners a été […]
Communiqué de presse
Sofinnova Partners Announces Third Investment from its Italian Fund This investment brings the total financing by Sofinnova Partners to €25 million over the past six months
MILAN, Italy – April 20, 2020 – Sofinnova Partners, a leading European life sciences venture capital firm based in […]